State Street Corp Aurinia Pharmaceuticals Inc. Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, State Street Corp holds 2,795,090 shares of AUPH stock, worth $31.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,795,090

Previous 2,851,166 1.97%

Holding current value

$31.6 Million

Previous $22.9 Million 3.28%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$7.2 - $8.64 $403,747 - $484,496	-56,076 Reduced 1.97%	2,795,090 $23.7 Million
Q1 2025 May 15, 2025	SELL	$7.55 - $8.77 $504,891 - $586,476	-66,873 Reduced 2.29%	2,851,166 $22.9 Million
Q4 2024 Feb 14, 2025	SELL	$6.75 - $10.44 $182,391 - $282,099	-27,021 Reduced 0.92%	2,918,039 $26.2 Million
Q3 2024 Nov 14, 2024	BUY	$5.32 - $7.33 $345,528 - $476,076	64,949 Added 2.26%	2,945,060 $21.6 Million
Q2 2024 Aug 14, 2024	BUY	$4.81 - $5.78 $525,478 - $631,447	109,247 Added 3.94%	2,880,111 $16.4 Million
Q1 2024 May 15, 2024	BUY	$4.93 - $9.31 $327,756 - $618,947	66,482 Added 2.46%	2,770,864 $13.9 Million
Q4 2023 Feb 14, 2024	BUY	$7.13 - $9.49 $747,559 - $994,998	104,847 Added 4.03%	2,704,382 $24.3 Million
Q3 2023 Nov 14, 2023	SELL	$7.77 - $12.27 $256,029 - $404,308	-32,951 Reduced 1.25%	2,599,535 $20.2 Million
Q2 2023 Aug 14, 2023	BUY	$8.96 - $11.69 $470,167 - $613,421	52,474 Added 2.03%	2,632,486 $25.5 Million
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $774,962 - $1.47 Million	130,465 Added 5.33%	2,580,012 $28.3 Million
Q4 2022 Feb 14, 2023	BUY	$4.11 - $8.14 $33,344 - $66,039	8,113 Added 0.33%	2,449,547 $10.6 Million
Q3 2022 Nov 15, 2022	BUY	$6.66 - $12.39 $356,789 - $663,757	53,572 Added 2.24%	2,441,434 $18.4 Million
Q2 2022 Aug 15, 2022	BUY	$8.95 - $12.8 $16.7 Million - $23.9 Million	1,863,594 Added 355.47%	2,387,862 $24 Million
Q1 2022 May 16, 2022	BUY	$10.05 - $22.48 $1.45 Million - $3.25 Million	144,586 Added 38.08%	524,268 $6.49 Million
Q4 2021 Feb 14, 2022	BUY	$17.78 - $33.08 $87,904 - $163,547	4,944 Added 1.32%	379,682 $8.68 Million
Q3 2021 Nov 15, 2021	BUY	$10.93 - $23.55 $4.1 Million - $8.83 Million	374,738 New	374,738 $8.29 Million

Others Institutions Holding AUPH

# of Institutions

243

Shares Held

62.3M

Call Options Held

1.03M

Put Options Held

665K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.61B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Aurinia Pharmaceuticals Inc. Transaction History